Artwork

Content provided by Mentored. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mentored or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Breaking Ground in Cancer Research: Going Public w/ Dr Alan Taylor from Clarity Pharmaceuticals

51:10
 
Share
 

Manage episode 398031179 series 1511965
Content provided by Mentored. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mentored or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

With Stake, Australia's leading investing platform, I'm excited to share the sixth episode of 'Going Public' - a new monthly series giving you unique access to the entrepreneurs, founders and executives who've taken their business public.


Clarity Pharmaceuticals is a clinical-stage cancer biotech company based in Australia. The company specializes in developing radiopharmaceutical products that can be used to image and diagnose various types of cancer. Clarity Pharmaceuticals is actively involved in extensive research, development, and clinical stage evaluation of its portfolio of novel radiopharmaceutical products. It was recently listed on the ASX in 2021 under the ticker CU6.


DISCLAIMER:

Views expressed are those of the individual only. This does not constitute financial advice.

You can subscribe to the newsletter here: https://lnkd.in/e7C8akgj.

Join the Facebook Group.

Follow Mark Bouris on Instagram, LinkedIn & YouTube.

See omnystudio.com/listener for privacy information.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

469 episodes

Artwork
iconShare
 
Manage episode 398031179 series 1511965
Content provided by Mentored. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mentored or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

With Stake, Australia's leading investing platform, I'm excited to share the sixth episode of 'Going Public' - a new monthly series giving you unique access to the entrepreneurs, founders and executives who've taken their business public.


Clarity Pharmaceuticals is a clinical-stage cancer biotech company based in Australia. The company specializes in developing radiopharmaceutical products that can be used to image and diagnose various types of cancer. Clarity Pharmaceuticals is actively involved in extensive research, development, and clinical stage evaluation of its portfolio of novel radiopharmaceutical products. It was recently listed on the ASX in 2021 under the ticker CU6.


DISCLAIMER:

Views expressed are those of the individual only. This does not constitute financial advice.

You can subscribe to the newsletter here: https://lnkd.in/e7C8akgj.

Join the Facebook Group.

Follow Mark Bouris on Instagram, LinkedIn & YouTube.

See omnystudio.com/listener for privacy information.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

469 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide